Quirk Gerald E 4
4 · Syros Pharmaceuticals, Inc. · Filed Oct 13, 2022
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Restricted Stock Units
2022-10-11+45,000→ 45,000 total→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs will vest as to one half (50%) of the shares on October 11, 2023, and as to one half (50%) of the shares on March 31, 2024.